Press Releases Elevation Oncology, Inc.

Equities

ELEV

US28623U1016

Market Closed - Nasdaq Other stock markets 03:59:52 2024-05-30 pm EDT			5-day change	1st Jan Change
4.07 ^USD	+2.52%		+10.30%	+657.91%

May. 14	Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target	MT
May. 02	Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution and Cash Liquidating Dividend Amount of $15.10 per Share of Common Stock	May. 13	AQ
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements	May. 03	AQ
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements	Mar. 07	AQ
Elevation Oncology to Participate in Upcoming Investor Conferences	Feb. 29	AQ
Kaskela Law LLC Announces Shareholder Investigation of Elevation Oncology (ELEV) and Encourages Investors to Contact the Firm	Feb. 29	PR
Merrimack Reports Ipsen Announcement of Approval by The US FDA of Onivyde Plus 5 Fluorouracil/Leucovorin and Oxaliplatin as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma	Feb. 14	AQ
Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors	Jan. 23	AQ
Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL	Jan. 17	AQ
Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference	Nov. 23	AQ
Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements	Nov. 03	AQ
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-06	AQ
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements	23-08-04	AQ
Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer	23-07-14	AQ
Elevation Oncology Announces Pricing of $50 Million Public Offering	23-06-08	PR
Elevation Oncology Announces Launch of Proposed Public Offering	23-06-08	PR
Elevation Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Business Achievements	23-05-16	AQ
ELEVATION ONCOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-15	AQ
ELEVATION ONCOLOGY, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	23-04-17	AQ
Elevation Oncology Reports Fourth Quarter and Full Year 2022 Financial Results	23-03-09	PR
ELEVATION ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Elevation Oncology, Inc.

Equities

ELEV

US28623U1016

Press Releases

Filters